scholarly article | Q13442814 |
P356 | DOI | 10.1136/JNNP-2013-306839 |
P698 | PubMed publication ID | 25121571 |
P50 | author | Leonard H van den Berg | Q56999697 |
Jan H Veldink | Q76753542 | ||
Martijn P van den Heuvel | Q45341736 | ||
P2093 | author name string | Esther Verstraete | |
Henk-Jan Westeneng | |||
Jeroen Hendrikse | |||
Renée Walhout | |||
P2860 | cites work | Motor unit number index (MUNIX): a novel neurophysiological technique to follow disease progression in amyotrophic lateral sclerosis | Q46823843 |
Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes | Q48012045 | ||
Effects of limb immobilization on brain plasticity. | Q48710977 | ||
Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease | Q48831225 | ||
Abnormal rich club organization and functional brain dynamics in schizophrenia. | Q50849084 | ||
Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS. | Q50939029 | ||
Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study. | Q51609288 | ||
Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. | Q54291831 | ||
Neuroimaging in amyotrophic lateral sclerosis | Q57498892 | ||
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis | Q57498933 | ||
Sensorimotor Functional Connectivity Changes in Amyotrophic Lateral Sclerosis | Q57911767 | ||
Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases | Q59116538 | ||
Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS | Q28198830 | ||
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis | Q29619074 | ||
Multipoint incremental motor unit number estimation as an outcome measure in ALS. | Q30425928 | ||
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis | Q30660585 | ||
Sporadic lower motor neuron disease with adult onset: classification of subtypes | Q30784695 | ||
Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI data | Q31063278 | ||
Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study | Q33741815 | ||
Highly accurate inverse consistent registration: a robust approach | Q34160493 | ||
The cortical signature of amyotrophic lateral sclerosis | Q34374772 | ||
Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis | Q34392278 | ||
The central nervous system in motor neurone disease | Q37069867 | ||
Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies | Q37959252 | ||
Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis? | Q38002017 | ||
Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis | Q39688083 | ||
Avoiding asymmetry-induced bias in longitudinal image processing. | Q40461274 | ||
Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis | Q41836892 | ||
Detection of motor cortex thinning and corticospinal tract involvement by quantitative MRI in amyotrophic lateral sclerosis | Q43511549 | ||
Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality | Q43739867 | ||
Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis | Q44963319 | ||
An anatomical substrate for integration among functional networks in human cortex. | Q45150218 | ||
Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis | Q45341661 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
P304 | page(s) | 288-294 | |
P577 | publication date | 2014-08-13 | |
P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
P1476 | title | Cortical thickness in ALS: towards a marker for upper motor neuron involvement | |
P478 | volume | 86 |
Q36479616 | ALS biomarkers for therapy development: State of the field and future directions |
Q90351947 | Abnormal topological organization of structural covariance networks in amyotrophic lateral sclerosis |
Q92378722 | Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis |
Q26747024 | Assessment of the upper motor neuron in amyotrophic lateral sclerosis |
Q64079969 | Biomarkers in Motor Neuron Disease: A State of the Art Review |
Q39413097 | Biomarkers in Neurodegenerative Diseases |
Q36405198 | Brain Parenchymal Fraction: A Relatively Simple MRI Measure to Clinically Distinguish ALS Phenotypes |
Q48106291 | Brain functional connectome abnormalities in amyotrophic lateral sclerosis are associated with disability and cortical hyperexcitability. |
Q64228443 | Clinical Measures of Bulbar Dysfunction in ALS |
Q56525449 | Combinatory Biomarker Use of Cortical Thickness, MUNIX, and ALSFRS-R at Baseline and in Longitudinal Courses of Individual Patients With Amyotrophic Lateral Sclerosis |
Q38710593 | Computer-based magnetic resonance imaging as a tool in clinical diagnosis in neurodegenerative diseases. |
Q93199197 | Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease |
Q30365956 | Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis. |
Q92289432 | Dominant Heterogeneity of Upper and Lower Motor Neuron Degeneration to Motor Manifestation of Involved Region in Amyotrophic Lateral Sclerosis |
Q48869495 | Emergence of an imaging biomarker for amyotrophic lateral sclerosis: is the end point near? |
Q38856405 | Further development of biomarkers in amyotrophic lateral sclerosis. |
Q40198465 | High-Resolution 7T MR Imaging of the Motor Cortex in Amyotrophic Lateral Sclerosis |
Q58556498 | Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis |
Q40924837 | Linking contemporary high resolution magnetic resonance imaging to the von Economo legacy: A study on the comparison of MRI cortical thickness and histological measurements of cortical structure. |
Q91596945 | Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters? |
Q42103824 | Longitudinal evaluation of cerebral and spinal cord damage in Amyotrophic Lateral Sclerosis |
Q92388747 | MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis |
Q37150806 | Marked changes in dendritic structure and spine density precede significant neuronal death in vulnerable cortical pyramidal neuron populations in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis |
Q48377031 | Mind the gap: the mismatch between clinical and imaging metrics in ALS. |
Q48103956 | Morphometric correlates of dysarthric deficit in amyotrophic lateral sclerosis |
Q41272501 | Multimodal structural MRI in the diagnosis of motor neuron diseases |
Q38983572 | Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis |
Q38384260 | Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis |
Q38804865 | Pathophysiological and diagnostic implications of cortical dysfunction in ALS. |
Q92202377 | Patterned functional network disruption in amyotrophic lateral sclerosis |
Q54387643 | Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies. |
Q48647819 | Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS. |
Q54988921 | Prefrontal cortical thickness in motor neuron disease. |
Q48612819 | Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS. |
Q48331848 | Semiautomated Evaluation of the Primary Motor Cortex in Patients with Amyotrophic Lateral Sclerosis at 3T. |
Q59901889 | Significance of CSF NfL and tau in ALS |
Q48934859 | Structural brain correlates of cognitive and behavioral impairment in MND. |
Q33701772 | Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state |
Q91572614 | Texture Analysis to Detect Cerebral Degeneration in Amyotrophic Lateral Sclerosis |
Q28067928 | The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review |
Q27007017 | What does imaging reveal about the pathology of amyotrophic lateral sclerosis? |
Search more.